Medicare Benefits Schedule - Note TN.1.12

Search Results for Note TN.1.12

View Related Items

Category 3 - THERAPEUTIC PROCEDURES

TN.1.12

Cytotoxic Chemotherapy Administration - (Item 13915)

Following a recommendation of a National Health and Medical Research Council review committee in 2005, Medicare benefits are no longer payable for professional services rendered for the purpose of administering microwave (UHF radiowave) cancer therapy, including the intravenous injection of drugs used in the therapy.

Related Items: 13915


Related Items

Category 3 - THERAPEUTIC PROCEDURES

13915

13915 - Additional Information

Item Start Date:
01-Jul-1993
Description Updated:
01-May-2006
Schedule Fee Updated:
01-Jul-2020

CYTOTOXIC CHEMOTHERAPY, administration of, either by intravenous push technique (directly into a vein, or a butterfly needle, or the side-arm of an infusion) or by intravenous infusion of not more than 1 hours duration - payable once only on the same day, not being a service associated with photodynamic therapy with verteporfin or for the administration of drugs used immediately prior to, or with microwave (UHF radiowave) cancer therapy alone

Fee: $67.10 Benefit: 75% = $50.35 85% = $57.05

(See para TN.1.12 of explanatory notes to this Category)


Legend

  • Assist - Addition/Deletion of (Assist.)
  • Amend - Amended Description
  • Anaes - Anaesthetic Values Amended
  • Emsn - EMSN Change
  • Fee - Fee Amended
  • Renum - Item Number Change (renumbered)
  • New - New Item
  • NewMin - New Item (previous Ministerial Determination)
  • Qfe - QFE Change